Female urinary tract infections in clinical practice. ([2020])

• Record Type: Book
• Further Information: Note: Bob Yang, Steve Foley, editors.
• Editors: Yang, Bob; Foley, Steve
• Contents: Intro; Introduction; Contents; Chapter 1: Pathophysiology of UTIs; 1.1 Six Categories of UTIs; 1.2 How Do UTIs Occur?; 1.3 Natural Defences; 1.4 What Are the Risk Factors and Why?; 1.5 Gender-Related; 1.6 Functional; 1.7 Disease-Related/Iatrogenic; 1.8 Genetic; 1.9 Asymptomatic Bacteriuria; References; Chapter 2: Presentation and Diagnosis; 2.1 Clinical Symptoms; 2.2 History; 2.3 Examination; 2.4 Urine Analysis; 2.5 Further Investigations; References; Chapter 3: Role of Imaging in UTIs; 3.1 Introduction; 3.2 Diagnostic Indications; 3.3 Imaging Modalities; 3.4 Uncomplicated UTI 3.5 Complicated UTI3.6 Imaging Findings in Acute UTI; 3.6.1 Cystitis; 3.6.2 Pyelonephritis; 3.6.3 Hydronephrosis and Pyonephrosis; 3.6.4 Pyonephrosis; 3.6.5 Renal Abscess; 3.7 Imaging in Recurrent UTIs; 3.7.1 Chronic Pyelonephritis; 3.7.2 Urinary Tract Tuberculosis; References; Chapter 4: Antibiotics; 4.1 Trimethoprim; 4.2 Nitrofurantoin; 4.3 Penicillin; 4.4 Fluoroquinolones; 4.5 Aminoglycosides; 4.6 Fosfomycin; 4.7 Cephalosporin; 4.8 Carbapenems; 4.9 Multidrug-Resistance Bacteria; 4.10 Antibiotics Prophylaxis; References; Chapter 5: Lifestyle Modifications; 5.1 Introduction 5.2 Oral Hydration5.3 Sexual Hygiene; 5.4 Personal Hygiene; 5.5 Voiding; 5.6 Weight Loss; References; Chapter 6: Cranberry; 6.1 Introduction and Mechanism of Action; 6.2 Clinical Evidence; References; Chapter 7: d-Mannose; 7.1 Introduction and Mechanism of Action; 7.2 Clinical Evidence; References; Chapter 8: Methenamine Hippurate (Hiprex); 8.1 Introduction and Mechanism of Action; 8.2 Clinical Evidence; References; Chapter 9: Oestrogen Replacement Therapy; 9.1 Introduction and Mechanism of Action; 9.2 Clinical Evidence; 9.3 Oral Oestrogen; References; Chapter 10: Traditional Chinese Medicine 10.1 Introduction and Mechanism of Action10.2 Formulations; 10.3 Clinical Evidence; 10.4 Acupuncture; References; Chapter 11: Intravesical Therapies; 11.1 Introduction; 11.2 The Procedure Itself; 11.3 Intravesical Antibiotics (IVA); 11.4 Clinical Evidence; 11.5 Non-antibiotic Instillations (GAG Layer Replacement); 11.6 Clinical Evidence; 11.7 Limitation of Intravesical Therapies; References; Chapter 12: Fractional CO2 Thermo-Ablative Vaginal Laser Therapy; 12.1 Introduction and Mechanism of Action; 12.2 Clinical Evidence; References; Chapter 13: Immunomodulation Vaccines 13.1 Introduction and Mechanism of Action13.2 Clinical Evidence; 13.2.1 UroVaxom®; 13.2.2 Urovac®; 13.2.3 ExPEC4V; 13.2.4 Uromune®; References; Chapter 14: Urinary Tract Infections of the Neurogenic Bladder; 14.1 Pathophysiology; 14.1.1 Precipitating Factors; 14.1.1.1 Voiding; 14.1.1.2 Catheters; 14.1.1.3 Stones; 14.1.1.4 Obstruction; 14.1.1.5 Bowel Dysfunction; 14.2 Definition of UTI in NLUT; 14.2.1 Urine Analysis; 14.2.2 Positive Urine Culture; 14.3 Clinical Evaluation of Neurogenic Bladder; 14.3.1 Clinical Examination and Investigations
• Publisher Details: Cham, Switzerland : Springer
• Publication Date: 2020
• Extent: 1 online resource (viii, 108 pages)
• Subjects: 616.6; Urinary tract infections -- Diagnosis; Urinary tract infections -- Treatment; Urinary tract infections -- Prevention; Urinary Tract Infections -- diagnosis; Urinary tract infections; Electronic books; Electronic books
• Languages: English
• ISBNs: 9783030279097
• Related ISBNs: 303027909X; 9783030279080; 3030279081
• Notes: Note: Includes bibliographical references and index.; Note: Description based on print version record.
• Access Rights: Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
• Access Usage: Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.